Remdesivir for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial)

NCT06729593 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

87

Enrollment

NIH

Sponsor class

Conditions

Covid19

Interventions

BIOLOGICAL: Remdesivir
BIOLOGICAL: Remdesivir Placebo
DRUG: Corticosteroid

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]